Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PathoVax

PathoVax
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
9 INVESTORS
Description

Developer of an HPV vaccine to better combat the infectious disease. The company develops and commercializes a broad spectrum vaccine for treatment of human papillomavirus.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 1812 Ashland Avenue
  • Suite 100
  • Baltimore, MD
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PathoVax’s full profile, request a free trial.

PathoVax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Accelerator/Incubator 21-May-2019 00.000 Completed Startup
9. Grant 01-Jan-2018 00000 00.000 Completed Startup
8. Grant 21-Dec-2017 00000 00.000 Completed Startup
7. Grant 18-Sep-2017 00000 00.000 Completed Startup
6. Accelerator/Incubator 28-Oct-2016 00000 00.000 Completed Startup
5. Angel (individual) 24-May-2016 00000 00000 Completed Startup
4. Accelerator/Incubator 15-Jan-2016 Completed Startup
3. Grant 01-Jul-2015 00000 Completed Startup
2. Grant 01-May-2015 $10K Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

PathoVax Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
National Institutes of Allergy and Infectious Disease Government Minority 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
43North Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

PathoVax Executive Team (4)

Name Title Board
Seat
Contact
Info
Nicholas Calcaterra Ph.D Co-Founder & Interim Chief Financial Officer
Joshua Wang Ph.D Co-Founder
Weijie Poh Ph.D Co-Founder

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »